文献速递慢性肾脏病肾小球疾病

2型糖尿病患者尿白蛋白-肌酐比值的变异性:临床与研究启示

Urine Albumin-Creatinine Ratio Variability in People With Type 2 Diabetes: Clinical and Research Implications.
PubMed 文献 · Am J Kidney Dis · 2024-03-15

本研究基于PREDICT队列826例2型糖尿病患者,在4周内采集4次随机尿样测定UACR,量化个体内变异性。结果显示UACR个体内变异系数达48.8%,单次测量变化解读可靠性低,多次采集可提高监测能力但诊断或非必需。

要点

  • UACR个体内变异系数48.8%,重复测量值可达首次的0.26至3.78倍。
  • 单次UACR从2升至5mg/mmol时,真实增加≥30%的概率仅50%。
  • 每个时间点采集2次可使该概率升至97%,诊断不确定范围随采集次数增加而缩窄。

核心结论

  • 2型糖尿病患者UACR存在高度个体内变异性,多次尿液采集可改善监测能力,但诊断白蛋白尿未必需要。

研究设计与样本

  • 描述性横断面分析,纳入PREDICT队列中826例2型糖尿病患者(67.1岁,64.9%男性),4周内采集4次随机尿测定UACR。

主要发现

  • UACR个体内变异系数48.8%,95%随机变异限显示重复UACR可为首次的3.78或0.26倍。
  • 单次UACR从2升至5mg/mmol时,真实增加≥30%的概率仅50%,每个时间点采集2次时升至97%。
  • 初始UACR后诊断不确定范围为2.0-4.0mg/mmol,2次和3次采集均值分别缩窄至2.4-3.2和2.7-2.9mg/mmol。
  • 女性及中度白蛋白尿与较高个体内UACR变异相关,eGFR降低及SGLT2i/ACEi/ARB治疗与较低变异相关。

关键数值与推荐

  • UACR个体内变异系数48.8%,95%随机变异限为首次值的0.26-3.78倍。
  • 单次UACR 2→5mg/mmol时真实增加≥30%的概率50%,2次采集时97%。
  • 诊断不确定范围:初始检测后2.0-4.0mg/mmol,2次均值2.4-3.2mg/mmol,3次均值2.7-2.9mg/mmol。

临床怎么用

  • 临床解读UACR变化时应考虑高度个体内变异,单次测量变化不可靠。
  • 监测UACR变化时建议多次采集,每个时间点2次可显著提高判断真实变化的把握度。
  • 诊断白蛋白尿时多次采集可能并非必需,但监测和研究中多次采集有助于区分真实变化与随机变异。

局限性

  • 以4次UACR采集的均值作为白蛋白尿参考标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Evidence has demonstrated that albuminuria is a key diagnostic and prognostic marker of diabetic chronic kidney disease, but the impact of its day-to-day variability has not been adequately considered. This study quantified within-individual variability of albuminuria in people with type 2 diabetes to inform clinical albuminuria monitoring. STUDY DESIGN: Descriptive cross-sectional analysis. SETTING & PARTICIPANTS: People with type 2 diabetes (n=826, 67.1 [IQR, 60.3-72.4] years, 64.9% male) participating in the Progression of Diabetic Complications (PREDICT) cohort study. EXPOSURE: Four spot urine collections for measurement of urinary albumin-creatinine ratio (UACR) within 4 weeks. OUTCOME: Variability of UACR. ANALYTICAL APPROACH: We characterized within-individual variability (coefficient of variation [CV], 95% limits of random variation, intraclass correlation coefficient), developed a calculator displaying probabilities that any observed difference between a pair of UACR values truly exceeded a 30% difference, and estimated the ranges of diagnostic uncertainty to inform a need for additional UACR collections to exclude or confirm albuminuria. Multiple linear regression examined factors influencing UACR variability. RESULTS: We observed high within-individual variability (CV 48.8%; 95% limits of random variation showed a repeated UACR to be as high/low as 3.78/0.26 times the first). If a single-collection UACR increased from 2 to 5mg/mmol, the probability that UACR actually increased by at least 30% was only 50%, rising to 97% when 2 collections were obtained at each time point. The ranges of diagnostic uncertainty were 2.0-4.0mg/mmol after an initial UACR test, narrowing to 2.4-3.2 and 2.7-2.9mg/mmol for the mean of 2 and 3 collections, respectively. Some factors correlated with higher (female sex; moderately increased albuminuria) or lower (reduced estimated glomerular filtration rate and sodium-glucose cotransporter 2 inhibitor/angiotensin-converting enzyme inhibitor/angiotensin receptor blocker treatment) within-individual UACR variability. LIMITATIONS: Reliance on the mean of 4 UACR collections as the reference standard for albuminuria. CONCLUSIONS: UACR demonstrates a high degree of within-individual variability among individuals with type 2 diabetes. Multiple urine collections for UACR may improve capacity to monitor changes over time in clinical and research settings but may not be necessary for the diagnosis of albuminuria. PLAIN-LANGUAGE SUMMARY: Albuminuria (albumin in urine) is a diagnostic and prognostic marker of diabetic chronic kidney disease. However, albuminuria can vary within an individual from day to day. We compared 4 random spot urinary albumin-creatinine ratio (UACR) samples from 826 participants. We found that a second UACR collection may be as small as a fourth or as large as almost 4 times the first sample's UACR level. This high degree of variability presents a challenge to our ability to interpret changes in albuminuria. Multiple collections have been suggested as a solution. We have constructed tools that may aid clinicians in deciding how many urine collections are required to monitor and diagnose albuminuria. Multiple urine collections may be required for individual monitoring but not necessarily for diagnosis.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Rasaratnam N, Salim A, Blackberry I, et al. Urine Albumin-Creatinine Ratio Variability in People With Type 2 Diabetes: Clinical and Research Implications. Am J Kidney Dis. 2024. PMID: 38551531. doi:10.1053/j.ajkd.2023.12.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。